Cargando…
Deletion of IP6K1 in mice accelerates tumor growth by dysregulating the tumor-immune microenvironment
A family of inositol hexakisphosphate kinases (IP6Ks) catalyzes the production of inositol pyrophosphate IP(7) (5-diphosphoinositolpentakisphosphate) which is known to modulate various biological events such as cell growth. While targeting IP6K1 in various cancer cells has been well reported to cont...
Autores principales: | Lee, Haein, Park, Seung Ju, Hong, Sehoon, Lim, Seol-Wa, Kim, Seyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8928833/ https://www.ncbi.nlm.nih.gov/pubmed/35308129 http://dx.doi.org/10.1080/19768354.2022.2029560 |
Ejemplares similares
-
Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors
por: Ahn, Myunghwan, et al.
Publicado: (2023) -
Drug discovery inspired by bioactive small molecules from nature
por: Kim, Seyun, et al.
Publicado: (2022) -
Stk10 Deficiency in Mice Promotes Tumor Growth by Dysregulating the Tumor Microenvironment
por: Ma, Jin-Xia, et al.
Publicado: (2022) -
Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment
por: Du, Juan, et al.
Publicado: (2020) -
Strategies to overcome DC dysregulation in the tumor microenvironment
por: Mestrallet, Guillaume, et al.
Publicado: (2022)